Form preview

Get the free 8K-filed-on-6-12-17 - Sorrento Therapeutics

Get Form
405 of this chapter or Rule 12b-2 of the Securities Exchange Act of 1934 240. 12b-2 of this chapter. 425 Soliciting material pursuant to Rule 14a-12 under the Exchange Act 17 CFR 240. 14a-12 Pre-commencement communications pursuant to Rule 14d-2 b under the Exchange Act 17 CFR 240. Http //photos. prnewswire. com/prnh/20150105/167173LOGO SOURCE Sorrento Therapeutics Inc. 2017 Sorrento Therapeutics Inc. All Rights Reserved. Contacts President Chief Executive Officer Tel 858 668-6923 hji...
We are not affiliated with any brand or entity on this form
4,4
98,753 Reviews
4,5
11,210 Reviews
4,6
715 Reviews
4,6
789 Reviews

Get, Create, Make and Sign 8k-filed-on-6-12-17 - sorrento formrapeutics

Edit
Edit your 8k-filed-on-6-12-17 - sorrento formrapeutics form online
Type text, complete fillable fields, insert images, highlight or blackout data for discretion, add comments, and more.
Add
Add your legally-binding signature
Draw or type your signature, upload a signature image, or capture it with your digital camera.
Share
Share your form instantly
Email, fax, or share your 8k-filed-on-6-12-17 - sorrento formrapeutics form via URL. You can also download, print, or export forms to your preferred cloud storage service.

Editing 8k-filed-on-6-12-17 - sorrento formrapeutics online

9.5
Ease of Setup
pdfFiller User Ratings on G2
9.0
Ease of Use
pdfFiller User Ratings on G2
Follow the guidelines below to take advantage of the professional PDF editor:
1
Register the account. Begin by clicking Start Free Trial and create a profile if you are a new user.
2
Upload a file. Select Add New on your Dashboard and upload a file from your device or import it from the cloud, online, or internal mail. Then click Edit.
3
Edit 8k-filed-on-6-12-17 - sorrento formrapeutics. Add and change text, add new objects, move pages, add watermarks and page numbers, and more. Then click Done when you're done editing and go to the Documents tab to merge or split the file. If you want to lock or unlock the file, click the lock or unlock button.
4
Get your file. Select the name of your file in the docs list and choose your preferred exporting method. You can download it as a PDF, save it in another format, send it by email, or transfer it to the cloud.
With pdfFiller, it's always easy to deal with documents.

Uncompromising security for your PDF editing and eSignature needs

Your private information is safe with pdfFiller. We employ end-to-end encryption, secure cloud storage, and advanced access control to protect your documents and maintain regulatory compliance.
Learn more about security & compliance
GDPR
AICPA SOC 2
PCI
HIPAA
CCPA
FDA

How to fill out 8k-filed-on-6-12-17 - sorrento formrapeutics

Illustration

How to fill out 8k-filed-on-6-12-17 - sorrento formrapeutics

01
To fill out the 8k-filed-on-6-12-17 - sorrento formrapeutics, follow these steps:
02
Obtain the 8k form from the SEC's EDGAR database or Sorrento FormTherapeutics' official website.
03
Read through the instructions provided with the form to understand the filing requirements.
04
Gather all the necessary information and documents required for filling out the form, such as company details, financial information, and any relevant disclosures.
05
Open the form using a PDF editor or any appropriate software that can handle PDF files.
06
Ensure that you have the latest version of the form and check for any updates or revisions.
07
Fill in the required fields accurately and provide all the relevant information as requested.
08
Review the completed form thoroughly to ensure its accuracy and completeness.
09
Save a copy of the filled form for your records.
10
File the completed form electronically through the SEC's EDGAR system or as instructed by Sorrento FormTherapeutics.
11
Retain a copy of the submission confirmation or receipt for future reference.

Who needs 8k-filed-on-6-12-17 - sorrento formrapeutics?

01
Anyone who is associated with Sorrento FormTherapeutics and is required to disclose certain information or events to the SEC needs the 8k-filed-on-6-12-17 form. This includes company executives, directors, and other authorized individuals responsible for regulatory filings. The form is necessary to comply with the SEC's disclosure requirements and provide transparency to the investors and public regarding important events or changes in the company's operations, finances, or corporate structure.
Fill form : Try Risk Free
Users Most Likely To Recommend - Summer 2025
Grid Leader in Small-Business - Summer 2025
High Performer - Summer 2025
Regional Leader - Summer 2025
Easiest To Do Business With - Summer 2025
Best Meets Requirements- Summer 2025
Rate the form
4.5
Satisfied
26 Votes

For pdfFiller’s FAQs

Below is a list of the most common customer questions. If you can’t find an answer to your question, please don’t hesitate to reach out to us.

To distribute your 8k-filed-on-6-12-17 - sorrento formrapeutics, simply send it to others and receive the eSigned document back instantly. Post or email a PDF that you've notarized online. Doing so requires never leaving your account.
When you use pdfFiller's add-on for Gmail, you can add or type a signature. You can also draw a signature. pdfFiller lets you eSign your 8k-filed-on-6-12-17 - sorrento formrapeutics and other documents right from your email. In order to keep signed documents and your own signatures, you need to sign up for an account.
Use the pdfFiller mobile app to create, edit, and share 8k-filed-on-6-12-17 - sorrento formrapeutics from your iOS device. Install it from the Apple Store in seconds. You can benefit from a free trial and choose a subscription that suits your needs.
The 8k filed on 6-12-17 by Sorrento Formrapeutics is a form used to report important events or changes that are of interest to shareholders and the SEC.
Sorrento Formrapeutics, as a publicly traded company, is required to file the 8k form with the SEC.
The 8k form must be filled out accurately and completely, providing all required information about the event or change being reported.
The purpose of the 8k form is to inform shareholders and the SEC about significant events or changes within the company that may affect its financial performance or operations.
The 8k form must include details about the event or change being reported, the date it occurred, its impact on the company, and any relevant financial information.
Fill out your 8k-filed-on-6-12-17 - sorrento formrapeutics online with pdfFiller!

pdfFiller is an end-to-end solution for managing, creating, and editing documents and forms in the cloud. Save time and hassle by preparing your tax forms online.

Get started now
Form preview

8k-Filed-On-6-12-17 - Sorrento Formrapeutics is not the form you're looking for?Search for another form here.

Related Features

Clean Verse in the Training Evaluation Survey with ease
Change Stuff in the Salon Business Plan Template with ease
Change Stuff in the Vacation Request with ease
Remove Subject in the Marketing Agreement with ease
Remove Subject in the Sales Contract with ease

Relevant keywords

2017 1934 delaware washington celularity tnk therapeutics registrant cd38 celularitys cfr ji uncured 12b 14d 13e immuno 14a sublicense centric bloodderived tnks phd sorrentotherapeutics biopharmaceutical sublicensable appealable prnewswire 21e myeloma imm

Related Forms

Form preview
zapier pdffiller
Pto/sb/29 (08-08) approved for use through 06/30/2010. omb 0651-0032 u.s. patent and trademark office; u.s.
Fill Now
Form preview
suing
United states patent and trademark office commissioner for patents united states patent and trademark office
Fill Now
Form preview
form imm 5406
Pto/sb/94 (02-09) approved for use through 02/29/2012. omb 0651-0036 u.s. patent and trademark office; u.s.
Fill Now
Form preview
uspto customer number lookup
Pto/sb/125a (11-08) approved for use through 11/30/2011. omb 0651-0035 u.s. patent and trademark office, u.s.
Fill Now
Form preview
suspto
Doc code: .req.rear pto/sb/38 (07-09) approved for use through 07/31/2012. omb 0651-0031 u.s. patent and
Fill Now
If you believe that this page should be taken down, please follow our DMCA take down process here .
This form may include fields for payment information. Data entered in these fields is not covered by PCI DSS compliance.